Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 807 participants.

Also called NCT01499082

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 807 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01499082
  • EudraCT 2010-023769-23
Main results
  • New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1) Diabetes care, 2014-10 DOI, PubMed 25078900

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania, South Africa (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01499082. Randomized; no masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2015-04-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
Acronym
EDITION I
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
HOE901-U300 (new formulation of insulin glargine)
Intervention (Drug)
Lantus (insulin glargine)
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct01499082
Content hash
00380a30921ceb8b6ea94e59a094fcbd683eb36db5481f95a04a00183d230986